Martingale Asset Management L P Intellia Therapeutics, Inc. Transaction History

Martingale Asset Management L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 09, 2018	SELL	$20.02 - $30.79 $634,974 - $976,566	-31,717 Closed	0 $0
Q1 2018 May 11, 2018	SELL	$19.43 - $34.95 $5,829 - $10,485	-300 Reduced 0.94%	31,717 $0
Q4 2017 Feb 12, 2018	SELL	$17.39 - $31.12 $5,043 - $9,024	-290 Reduced 0.9%	32,017 $0
Q3 2017 Nov 13, 2017	BUY	$15.16 - $25.75 $489,774 - $831,905	32,307	32,307 $803,000

314

91.5M

442K

880K

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $775M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.